HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500052-MCP200v1 4/11/1664    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olle, E. W. Articles by Johnson, K. J. Search for Related Content PubMed PubMed Citation Articles by Olle, E. W. Articles by Johnson, K. J. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:1664-1672, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Development of an Internally Controlled Antibody Microarray^*

Eric W. Olle^,, Arun Sreekumar, Roscoe L. Warner, Shannon D. McClintock, Arul M. Chinnaiyan, Michael R. Bleavins^,, Timothy D. Anderson and Kent J. Johnson^,¶

From the Pfizer Global Research and Development, Ann Arbor, Michigan 48105 and the Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109

Antibody microarrays are a high throughput technology used to concurrently screen for protein expression. Most antibody arrays currently used are based on the ELISA sandwich approach that uses two antibodies to screen for the expression of a limited number of proteins. Also because antigen-antibody interactions are concentration-dependent, antibody microarrays need to normalize the amount of antibody that is used. In response to the limitations with the currently existing technology we have developed a single antibody-based microarray where the quantity of antibody spotted is used to standardize the antigen concentration. In addition, this new array utilizes an internally controlled system where one color represents the amount of antibody spotted, and the other color represents the amount of the antigen that is used to quantify the level of protein expression. When compared with median fluorescence intensity alone, normalization for antibody spot intensity decreased variability and lowered the limits of detection. This new antibody array was tested using standard cytokine proteins and also cell lysates obtained from mouse macrophages stimulated in vitro and evaluated for the expression of the cytokine proteins interleukin (IL)-1ß, IL-5, IL-6, and macrophage inflammatory proteins 1 and 1ß. The levels of protein expression seen with the antibody microarray was compared with that obtained with Western blot analysis, and the magnitude of protein expression observed was similar with both technologies with the antibody array actually showing a greater degree of sensitivity. In summary, we have developed a new type of antibody microarray to screen for protein expression that utilizes a single antibody and controls for the amount of antibody spotted. This type of array appears at least as sensitive as Western blot analysis, and the technology can be scaled up for high throughput screening for hundreds of proteins in complex biofluids such as blood.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Hartmann, M. Schrenk, A. Dottinger, S. Nagel, J. Roeraade, T. O. Joos, and M. F. Templin Expanding Assay Dynamics: A Combined Competitive and Direct Assay System for the Quantification of Proteins in Multiplexed Immunoassays Clin. Chem., June 1, 2008; 54(6): 956 - 963. [Abstract] [Full Text] [PDF]

				M. Sanchez-Carbayo Antibody Arrays: Technical Considerations and Clinical Applications in Cancer Clin. Chem., September 1, 2006; 52(9): 1651 - 1659. [Abstract] [Full Text] [PDF]